Ophthalmology Doctors in Racine, WI Accepting Medicare

5 Ophthalmology doctors found. Showing 1 - 5

Dr. Robert H Lehner Jr., M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3805a Spring St, Suite 111, Racine, WI 53405 Phone: 262-637-9615    Fax: 262-637-4437

Inder Paul Singh, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3805b Spring St, Suite 140, Racine, WI 53405 Phone: 262-637-8835    Fax: 262-635-8027

Dennis J Kontra, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 5802 Washington Ave, Ste 102, Racine, WI 53406 Phone: 262-886-9100    Fax: 262-886-9130

Dr. Donna R Daufenbach, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5333 Douglas Ave, Racine, WI 53402 Phone: 262-752-2100    Fax: 262-752-2126

Mr. Ronald L Allen, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 4060 N Main St, Racine, WI 53402 Phone: 262-752-2020

News Archive

Plea for every human to have access to safe drinking water

A plea to the world's physicians and health authorities to do more to support measures to provide access to safe drinking water at low cost to every human on the planet has been made by the World Medical Association.

Improved cell therapy for cartilage repair

Artificially cultured cartilage cells, grown outside of the body for reparing damaged tissue, prove to be different from original cartilage tissue.

Health claim for omega-3 fatty acids should help consumers reduce risk of coronary heart disease

The Food and Drug Administration (FDA) today announced the availability of a qualified health claim for reduced risk of coronary heart disease (CHD) on conventional foods that contain eiscosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) omega-3 fatty acids.

Hypofractionated RT can reduce treatment time by half in stage II and III NSCLC patients

For patients with stage II and III non-small cell lung cancer (NSCLC) unable to receive standard treatments of surgery or chemoradiation (CRT), hypofractionated radiation therapy (RT) results in similar overall survival (OS) and progression-free survival (PFS) rates, limited severe side effects and shorter treatment times when compared to conventional RT, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

Corin unveils new Trinity Dual Mobility System for hip replacement at AAOS Annual Meeting

Corin, a global orthopedic manufacturer and leader in functional implant positioning, today announced the launch of the Trinity Dual Mobility System featuring new implant technology designed to improve range of motion and reduce the risk for instability and dislocation after primary or revision hip replacement.

Read more Medical News

› Verified 3 days ago